IZEA, Inc. — First-Quarter 2014 Form 10-Q
Reporting period: Three months ended March 31, 2014; comparative results are for the three months ended March 31, 2013. The filing identifies the registrant as IZEA, Inc. Its business is social sponsorship and native advertising, matching advertisers with social-media creators through online platforms. IZEA launched the public beta of its IZEA Exchange (IZEAx) platform on March 17, 2014.
Financial performance and position
| Metric | Q1 2014 | Q1 2013 / prior date |
|---|---|---|
| Revenue | $1.957 million | $1.385 million |
| Gross profit / margin | $1.308 million / 67% | $809,000 / 58% |
| Operating expenses | $2.005 million | $1.669 million |
| Operating loss | $698,000 | $860,000 |
| Net loss | $569,000; $0.02 per share | $884,000; $0.13 per share |
| Adjusted EBITDA, non-GAAP | $(504,000) | $(756,000) |
| Operating cash flow | $(22,000) | $(697,000) |
| Cash and cash equivalents | $11.250 million | $530,000 at Dec. 31, 2013 |
Cash from investing activities was $220,000, mainly for IZEAx development; financing activities provided $10.962 million, largely from the February equity financing. Current assets were $12.359 million and current liabilities $2.259 million at quarter-end. Capital-lease obligations totaled approximately $107,000, and no advances were outstanding under the $1.5 million Bridge Bank facility. The balance sheet also reported a $14.080 million warrant liability and a $3.275 million stockholders’ deficit.
Changes versus the prior comparable period
- Revenue increased 41.3%, driven by approximately $631,000 more sponsored revenue; media revenue decreased about $1,000 and service-fee revenue decreased about $58,000.
- Gross profit rose 61.6%, and gross margin improved by about nine percentage points. Management attributed this to growth in larger, managed advertiser campaigns.
- Operating expenses increased 20.1%, including higher stock compensation, investor-relations, software, travel, and launch-promotion costs.
- Net loss narrowed by $315,000. The comparison includes a $136,000 fair-value gain on derivatives in 2014 versus a net $8,000 fair-value expense in 2013; these non-cash valuation changes affect comparability.
- Operating cash use improved to $22,000 from $697,000, while quarter-end cash rose substantially following the private placement.
Outlook, risks, and unusual items
- Management expected Q2 2014 net bookings to exceed both Q1 2014 and Q2 2013. April bookings were nearly $1 million, reported as 230% above April 2013. Management uses bookings as an indicator of revenue generally recognized within 90 days; this is not a formal revenue or earnings forecast.
- The February 2014 private placement raised $12.0 million gross and $10.982 million net. Proceeds were intended for sales and marketing, strategic partnerships, technology development, working capital, and capital expenditures. Management stated the proceeds provided positive working capital and cash reserves for the foreseeable future, while also noting the company’s history of losses and negative operating cash flow.
- The financing included 34.3 million common shares and five-year warrants for up to 34.3 million shares at $0.35 and $0.50 per share, plus placement-agent warrants. The warrants are liability-classified and remeasured at fair value. Registration-related provisions and potential exercise-price adjustments are relevant; failure to meet registration obligations could trigger cash liquidated damages.
- IZEAx was still in public beta. Management planned continued development and disclosed that success, completion, customer adoption, and revenue contribution were uncertain. The company capitalized $207,000 of development payroll and benefits in Q1.
- Blue Calypso alleged patent infringement and sought unspecified damages. The case was stayed pending PTAB review of all five asserted patents; the company said it could not estimate the likelihood or amount of exposure and disputed the claims.
- After quarter-end, authorized common shares were increased from 100 million to 200 million, and the company adopted an employee stock purchase plan reserving 1.5 million shares. The company reported 57.0 million common shares outstanding as of May 9, 2014. Substantial potential dilution also exists from warrants, options, restricted shares, and plan reserves.
- Customer concentration warrants monitoring: three customers represented 51% of accounts receivable at March 31, 2014, and two customers accounted for 22% of Q1 revenue. The filing reported effective disclosure controls and no material Q1 change in internal control over financial reporting.
Investor verification points
- Track whether bookings growth converts into recognized revenue, and whether the Q2 booking outlook is achieved.
- Assess sustainable gross margins and progress toward operating and cash-flow break-even, excluding non-cash derivative valuation effects.
- Verify cash use, remaining runway, and execution against the stated uses of private-placement proceeds.
- Review warrant valuation, registration compliance and any cash penalties, as well as the dilution and potential resale impact of the financing securities.
- Monitor IZEAx development costs, launch progress, adoption, and whether capitalized software costs remain recoverable.
- Follow PTAB decisions and any developments in the Blue Calypso litigation; the filing does not quantify potential exposure.